rs45547937

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NR_171007.1(MIR1-1HG):n.788-179G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: NR_171007.1 is not a MANE Select or MANE Plus Clinical transcript for MIR1-1HG; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.232 (AC=84,166) in the gnomAD database across 363,416 control chromosomes, including 10,295 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.337. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 5181 hom., cov: 35)
Exomes 𝑓: 0.21 ( 5114 hom. )

Consequence

MIR1-1HG
NR_171007.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.809

Publications

5 publications found
Variant links:
Genes affected
MIR1-1HG (HGNC:16159): (MIR1-1 host gene) Predicted to be involved in miRNA-mediated post-transcriptional gene silencing. Predicted to be part of RISC complex. [provided by Alliance of Genome Resources, Jun 2026]
MIR133A2 (HGNC:31518): (microRNA 133a-2) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_171007.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.3367 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NR_171007.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MIR1-1HG NR_171007.1
HGVSc / HGVSpn.788-179G>A
Exon rankIntron 2 of 3
intron
Prot:
MIR133A2 NR_029676.1
HGVSc / HGVSpn.-102G>A
Exon rankN/A
upstream_gene
Prot:

Ensembl Transcripts

MIR1-1HG ENST00000624914.4
TSL:1
HGVSc / HGVSpn.794-179G>A
Exon rankIntron 2 of 3
intron
Prot:
MIR1-1HG ENST00000370523.4
TSL:5
HGVSc / HGVSpn.244-5634G>A
Exon rankIntron 2 of 2
intron
Prot:
MIR1-1HG ENST00000686477.2
HGVSc / HGVSpn.793-5634G>A
Exon rankIntron 2 of 2
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.255
AC:38734
Hom:5180
AN:152046
Cov:35
GnomAD4 exome
AF: 0.215
AC:45409
Hom:5114
AN:211252
GnomAD4 genome
AF: 0.255
AC:38757
Hom:5181
AN:152164
Cov:35
TOPMed (Bravo)
AF: 0.263
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.251
AC:6379
Hom:825
AN:25374
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.266
AC:622
Hom:93
AN:2342
ChinaMAP Phase 1
AF: 0.185
Denmark Genome
AF: 0.257
AC:77
AN:300
GenomeAsia100K
AF: 0.139
AC:484
AN:3476
Korea4K (4,157 Koreans)
AF: 0.172
AC:1247
AN:7230
Qatari Genome
AF: 0.244
AC:43
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.111
AC:13600
Hom:761
AN:122600
Turkish Variome
AF: 0.206
AC:318
Hom:30
AN:1546
UK10K
AF: 0.231
AC:1748
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.183
AC:1638
Hom:154
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.124 364429350 0.142 939466238
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.3
BayesDel_noAF
Benign-0.97
CADD
Benign9.3
DANN
Benign0.75
GPN-Star LLR
N/A-0.67
GPN-Star score
N/A0.67
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.81
Showing 8 of 8 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.